Novartis AG (NYSE:NVS) has received an average rating of “Hold” from the seventeen ratings firms that are currently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $83.19.
Several analysts have commented on the company. JPMorgan Chase & Co. restated a “neutral” rating on shares of Novartis in a report on Tuesday, October 24th. Nord/LB restated a “neutral” rating on shares of Novartis in a report on Tuesday, January 2nd. Bank of America cut Novartis from a “neutral” rating to an “underperform” rating in a report on Wednesday, December 6th. Leerink Swann lifted their price target on Novartis from $89.00 to $91.00 and gave the company a “market perform” rating in a report on Monday, October 23rd. Finally, UBS Group restated a “neutral” rating on shares of Novartis in a report on Monday, January 15th.
Novartis (NYSE:NVS) traded up $1.83 during trading on Wednesday, reaching $85.43. The company had a trading volume of 1,374,388 shares, compared to its average volume of 1,721,517. The company has a current ratio of 1.21, a quick ratio of 0.91 and a debt-to-equity ratio of 0.31. The stock has a market cap of $221,650.00, a PE ratio of 26.25, a PEG ratio of 1.95 and a beta of 0.74. Novartis has a 1 year low of $72.67 and a 1 year high of $94.19.
Large investors have recently modified their holdings of the company. WFG Advisors LP grew its holdings in shares of Novartis by 38.1% during the 2nd quarter. WFG Advisors LP now owns 1,221 shares of the company’s stock worth $102,000 after purchasing an additional 337 shares during the period. Wealthcare Advisory Partners LLC purchased a new stake in shares of Novartis during the 3rd quarter worth about $106,000. Cable Hill Partners LLC lifted its position in Novartis by 588.8% during the 3rd quarter. Cable Hill Partners LLC now owns 1,295 shares of the company’s stock worth $112,000 after acquiring an additional 1,107 shares in the last quarter. Pinnacle Wealth Planning Services Inc. acquired a new position in Novartis during the 4th quarter worth approximately $113,000. Finally, Calton & Associates Inc. acquired a new position in Novartis during the 4th quarter worth approximately $118,000. Institutional investors and hedge funds own 11.06% of the company’s stock.
Novartis Company Profile
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.
Receive News & Ratings for Novartis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis and related companies with MarketBeat.com's FREE daily email newsletter.